文献速递妇科产科

绝经后会发生什么?(WHAM):绝经前降低风险输卵管卵巢切除术后至12个月症状谱的前瞻性对照研究

What happens after menopause? (WHAM): A prospective controlled study of symptom profiles up to 12 months after pre-menopausal risk-reducing salpingo-oophorectomy.
PubMed 文献 · Gynecol Oncol · 2022-08-04

WHAM前瞻性对照研究纳入绝经前女性,比较保留卵巢对照组(n=99)、RRSO术后激素治疗(HT)组(n=57)和RRSO术后未用HT组(n=38),在基线及术后3、6、12个月测量更年期症状。潜类别转移分析识别出三种症状谱:多数症状、少数症状和性症状;未用HT组多数在3个月时报告多数症状且至12个月改善概率仅2%。

要点

  • RRSO术后识别出三种症状谱:多数症状、少数症状、性症状。
  • 未用HT者多数症状谱占比81-87%,至12个月改善概率仅2%。
  • HT使用者约三分之二症状较少,12个月改善概率12-32%。

核心结论

  • 绝经前RRSO后症状聚集成不同谱型,多数未用HT者症状重且12个月内改善机会小,而HT使用者约三分之二症状较少且改善机会更高。

研究设计与样本

  • 前瞻性纵向对照研究(WHAM),纳入绝经前女性,分三组:保留卵巢对照组99例、RRSO术后HT使用者57例、RRSO术后非HT使用者38例。
  • 在基线(术前)及术后3、6、12个月使用标准化问卷测量潮热、盗汗、性欲低、阴道干涩、睡眠差、焦虑/抑郁等症状。
  • 采用潜类别转移分析识别RRSO后症状谱及随时间转变的概率。

主要发现

  • 识别出三种症状谱:多数症状(非HT组81-87%,HT组36-41%,对照组7-9%)、少数症状(非HT组7-13%,HT组36-42%,对照组77-80%)、性症状(非HT组0-10%,HT组17-27%,对照组14-15%)。
  • 非HT组多数在3个月时报告多数症状,至12个月改善概率仅2%。
  • HT组在3个月时分布于不同谱型,至6个月改善概率5-13%(恶化概率14%),至12个月改善概率12-32%(恶化概率4-25%)。

临床怎么用

  • 这些发现可用于帮助患者决策和形成预期。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Understanding how symptoms cluster after premenopausal risk-reducing salpingo-oophorectomy (RRSO) can inform patient expectations but information is lacking. We aimed to identify symptom profiles after RRSO, changes over time, and the effect of hormone therapy (HT). METHOD: Participants were premenopausal women from a longitudinal controlled study (What Happens After Menopause? (WHAM)). Menopausal symptoms were prospectively measured in three groups: pre-menopausal comparisons who retained their ovaries (n = 99), RRSO HT users (n = 57) and RRSO non-HT users (n = 38). Symptoms (hot flashes, night sweats, low desire, vaginal dryness, poor sleep, anxiety/depression) were measured at baseline (pre-surgery) and at 3, 6 and 12 months using standardised questionnaires. Latent transition analysis was used to identify symptom profiles post-RRSO, and the probability of changing profiles over time. RESULTS: Three symptom profiles were identified: Most Symptoms (81-87% non-HT; 36-41% HT; 7-9% comparisons), Few Symptoms (7-13% non-HT; 36-42% HT; 77-80% comparisons), and Sexual Symptoms (0-10% non-HT; 17-27% HT; 14-15% comparisons). Most of the non-HT group reported Most Symptoms at 3 months with only a 2% chance of improvement by 12 months. The HT group were split between profiles at 3 months with a 5-13% chance of improvement by 6 months (14% chance of worsening), and a 12-32% chance of improvement by 12 months (4-25% chance of worsening). CONCLUSIONS: Symptoms cluster into distinct profiles after premenopausal RRSO. Most non-HT users are highly symptomatic with little chance of improvement by 12 months. In contrast, two-thirds of HT users have fewer symptoms and a much higher chance of improvement. These findings can inform patient decision-making and expectations.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Moss KM, Mishra GD, Krejany EO, et al. What happens after menopause? (WHAM): A prospective controlled study of symptom profiles up to 12 months after pre-menopausal risk-reducing salpingo-oophorectomy. Gynecol Oncol. 2022. PMID: 35933227. doi:10.1016/j.ygyno.2022.07.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。